Description
An α2-AR agonist (Kis = 61.66, 69.18, and 134.9 nM for α2A-, α2B-, and α2C-ARs, respectively); stimulates [35S]GTPγS binding to HEK293 cell membranes expressing human receptors (EC50s = 26.92, 56.23, and 912.01 nM for α2A-, α2B-, and α2C-ARs, respectively); binds to I1-imidazoline sites in a variety of cell and tissue types (Kds = 4-15 nM); induces relaxation of isolated mesenteric artery rings precontracted with norepinephrine at 10 μM; induces membrane hyperpolarization and reduces norepinephrine-induced depolarization in isolated mesenteric artery rings at 10 μM; reduces mean blood pressure and heart rate when administered via microinjection to the NRL of anesthetized normotensive cats at 0.1 and 1 μg/kg
Formal name: N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine, monohydrochloride
Synonyms: ST 155
Molecular weight: 266.6
CAS: 4205-91-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Ion Channel Modulation||Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Cardiovascular System|Cardiovascular Diseases|Hypertension||Research Area|Cardiovascular System|Vasculature|Vasodilation||Research Area|Neuroscience